Kitov Announces Filing by FDA of New Drug Application for KIT-302

TEL AVIV, Israel, October 2, 2017 /PRNewswire/ -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) filed the Company ' s New Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news